Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Forward PE Ratio : 0.00 (As of Jun. 04, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Forward PE Ratio?

Laboratorios Farmaceuticos Rovi's Forward PE Ratio for today is 0.00.

Laboratorios Farmaceuticos Rovi's PE Ratio without NRI for today is 33.67.

Laboratorios Farmaceuticos Rovi's PE Ratio for today is 33.75.

Laboratorios Farmaceuticos Rovi Forward PE Ratio Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Forward PE Ratio Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

2015-12

2016-12

2017-12

2018-12

2019-12

2020-12

2021-07

Forward PE Ratio

28.57

35.21

27.93

36.90

42.37

44.05

37.74

Laboratorios Farmaceuticos Rovi Quarterly Data
	2015-12	2016-03	2016-06	2016-09	2016-12	2017-03	2017-06	2017-09	2017-12	2018-03	2018-06	2018-09	2018-12	2019-03	2019-06	2019-09	2019-12	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06
Forward PE Ratio	28.57	23.75	37.88	23.98	35.21	34.84	40.65	27.86	27.93	54.95	50.00	30.40	36.90	38.31	59.52	34.36	42.37	33.33	40.16	31.95	44.05	30.86	35.46

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Forward PE Ratio

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorios Farmaceuticos Rovi's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Forward PE Ratio falls into.

Laboratorios Farmaceuticos Rovi Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Laboratorios Farmaceuticos Rovi Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK 41L:Germany

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.